The sale of antidepressants and mood elevators in India increased significantly, growing by 64% to Rs 2,536 crore since 2020, ...

There has been a new antidepressant on the market every two or three years. In 1987, the antidepressant fluoxetine (Prozac) was introduced. It had been tested by the FDA and found to be an ...

They suggest other fast-acting antidepressants could offer a competitive challenge to J&J's drug, including Axsome Therapeutics' recently approved Auvelity (bupropion/dextromethorphan), Sage ...

Growing awareness about fibromyalgia and advancements in treatment options drive market growth. Generic Medication Accessibility: Enhanced availability of generic medications for fibromyalgia ...

The sale of antidepressants and mood elevators in India surged from Rs 1,540 crore in 2020 to Rs 2,536 crore by Nov 2024.

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

"There are more than 30 antidepressants on the market but nine times out of 10 GPs prescribe one of just four antidepressants. "This means that patients may not get the treatment that would be ...

The data revealed that a combination of Escitalopram and Clonazepam was on top of the list, seeing an increase of 59.35% in sales since 2020.